Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n = 11,226).
Croall, Iain D
Lisiecka-Ford, Danuta M
Olorunda, Abiodun Olubunmi
Rost, Natalia S
Rothwell, Peter M
Sudlow, Cathie LM
International Stroke Genetics Consortium
Ovid Technologies (Wolters Kluwer Health)
MetadataShow full item record
Traylor, M., Tozer, D., Croall, I. D., Lisiecka-Ford, D. M., Olorunda, A. O., Boncoraglio, G., Dichgans, M., et al. (2019). Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n = 11,226).. Neurology, 92 (8), e749-e757. https://doi.org/10.1212/WNL.0000000000006952
OBJECTIVE: To identify novel genetic associations with white matter hyperintensities (WMH). METHODS: We performed a genome-wide association meta-analysis of WMH volumes in 11,226 individuals, including 8,429 population-based individuals from UK Biobank and 2,797 stroke patients. Replication of novel loci was performed in an independent dataset of 1,202 individuals. In all studies, WMH were quantified using validated automated or semi-automated methods. Imputation was to either the Haplotype Reference Consortium or 1,000 Genomes Phase 3 panels. RESULTS: We identified a locus at genome-wide significance in an intron of PLEKHG1 (rs275350, β [SE] = 0.071 [0.013]; p = 1.6 × 10-8), a Rho guanine nucleotide exchange factor that is involved in reorientation of cells in the vascular endothelium. This association was validated in an independent sample (overall p value, 2.4 × 10-9). The same single nucleotide polymorphism was associated with all ischemic stroke (odds ratio [OR] [95% confidence interval (CI)] 1.07 [1.03-1.12], p = 0.00051), most strongly with the small vessel subtype (OR [95% CI] 1.09 [1.00-1.19], p = 0.044). Previous associations at 17q25 and 2p16 reached genome-wide significance in this analysis (rs3744020; β [SE] = 0.106 [0.016]; p = 1.2 × 10-11 and rs7596872; β [SE] = 0.143 [0.021]; p = 3.4 × 10-12). All identified associations with WMH to date explained 1.16% of the trait variance in UK Biobank, equivalent to 6.4% of the narrow-sense heritability. CONCLUSIONS: Genetic variation in PLEKHG1 is associated with WMH and ischemic stroke, most strongly with the small vessel subtype, suggesting it acts by promoting small vessel arteriopathy.
International Stroke Genetics Consortium, Humans, Brain Ischemia, Polymorphism, Single Nucleotide, Adult, Aged, Middle Aged, Female, Male, Stroke, Genome-Wide Association Study, Cerebral Small Vessel Diseases, Stroke, Lacunar, Rho Guanine Nucleotide Exchange Factors, White Matter
This work was supported by a British Heart Foundation Programme Grant (RG/16/4/32218). Hugh Markus is supported by a National Institute for Health Research (NIHR) Senior Investigator award, and his work is supported by the Cambridge Universities NIHR Comprehensive Biomedical Research Centre. Loes Rutten-Jacobs was supported by a British Heart Foundation Immediate Research Fellowship (FS/15/61/31626). Natalia S. Rost is in part supported by NIH/NINDS R01NS086905 and R01NS082285. The MGH WMH study was supported by the National Institutes of Health (K23NS064052 - N.R.), American Heart Association/Bugher Foundation Centers for Stroke Prevention Research (0775010N), and Deane Institute for Integrative Study of Atrial Fibrillation and Stroke. Robin Lemmens is a senior clinical investigator of FWO Flanders.
British Heart Foundation (RG/16/4/32218)
Stroke Association (PPA 2015/02)
British Heart Foundation (FS/15/61/31626)
European Commission Horizon 2020 (H2020) Societal Challenges (667375)
Embargo Lift Date
External DOI: https://doi.org/10.1212/WNL.0000000000006952
This record's URL: https://www.repository.cam.ac.uk/handle/1810/288032
Attribution 4.0 International
Licence URL: http://creativecommons.org/licenses/by/4.0/